Salient Bio
PrivateLast Round
Seed
Sep 3, 2025
Total Funding Raised
$3.15M
Company Overview
Salient Bio is a biotechnology company that operates a diagnostic laboratory and develops non-invasive diagnostic tests by integrating synthetic biology, robotics, and microbiome metagenomics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Salient Bio Comparables
Compare Salient Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biome Diagnostics | 76% | |
| Hurdle | 71% | |
| Carbiotix | 70% |
Salient Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 3, 2025 |
Salient Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| THENA Capital | Seed |
Salient Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Salient Bio's valuation, stock price, and market status.
Is Salient Bio a public or private company?
Salient Bio is a private company.
What is the current stock price of Salient Bio?
Salient Bio is a private company, so its shares have no public market price. Caplight tracks Salient Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Salient Bio worth (valuation)?
Valuation information for Salient Bio is not publicly available.
Can I buy Salient Bio stock?
Salient Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Salient Bio's last funding round?
Salient Bio's most recent funding round was Seed on September 3, 2025.
Who are the main investors in Salient Bio?
Key investors in Salient Bio include THENA Capital.
Will Salient Bio IPO soon?
No public IPO plans have been announced for Salient Bio.
How can I track Salient Bio secondary market activity?
Caplight tracks bids, offers, and trades in Salient Bio's shares on secondary markets.